Dr. Steven Deeks is a distinguished leader in infectious disease research and clinical medicine with over three decades of transformative contributions to HIV science and patient care. He currently serves as a Professor of Medicine in Residence at the University of California, San Francisco and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. Since beginning his career in HIV research and clinical care in 1993, Dr. Deeks has established himself as an internationally recognized expert whose work bridges laboratory science and clinical practice. He maintains an active primary care practice for people living with HIV, demonstrating his enduring commitment to both patient care and scientific advancement.
Dr. Deeks has published over 650 peer-reviewed articles, editorials, and invited reviews that have fundamentally shaped our understanding of HIV pathogenesis, treatment, and cure strategies. As the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboration, he has spearheaded groundbreaking research aimed at developing therapeutic interventions to cure HIV infection. His expertise in HIV-associated immune dysfunction and its impact on viral persistence has positioned him at the forefront of efforts to understand and eliminate the HIV reservoir. Dr. Deeks also directed the amfAR Institute for HIV Cure Research and co-chairs the Towards an HIV Cure International Working Group, driving global collaboration in the pursuit of an HIV cure.
Recognized as one of the world's most influential scientists, Dr. Deeks is among the top 0.01% of all scientists based on citations, adjusted for authorship position and impact, and has been listed annually as one of the world's most cited scientists. He serves as editor-in-chief of Current Opinion in HIV and AIDS and sits on the scientific advisory board for Science Translational Medicine, significantly shaping the direction of research in his field. In early 2020, Dr. Deeks rapidly leveraged his HIV research expertise to establish the Long-term Impact of Infection with Novel Coronavirus (LIINC) cohort, which has become instrumental in understanding Long COVID pathogenesis. His 2022 receipt of the Lifetime Achievement in Mentoring Award from UCSF underscores his profound impact on training the next generation of researchers who continue to advance the fields of infectious diseases and immunology.
